Latest News about ABUS
Recent news which mentions ABUS
From Benzinga
From Benzinga
Tickers
ABUS
From InvestorPlace
Tickers
ABUS
From InvestorPlace
From InvestorPlace
From Benzinga
Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead
April 04, 2024
From Benzinga
Arbutus Stock Soars 20% As It Heads To Trial With Moderna In Covid Vaccine Patent Claim
April 03, 2024
From Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
From Benzinga
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute
October 05, 2023
From Benzinga
US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma
April 12, 2023
From Benzinga
Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots
April 04, 2023
From Benzinga
Arbutus Biopharma's Return On Capital Employed Insights
December 12, 2022
Tickers
ABUS
From Benzinga
From Benzinga
From InvestorPlace
Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know
August 26, 2022
From Benzinga
Arbutus Biopharma (ABUS) Q2 2022 Earnings Call Transcript
August 04, 2022
Tickers
ABUS
From Motley Fool
From Benzinga
From Benzinga
This Analyst Says Arbutus' EASL Presentations Outline Path For A Functional Cure For Chronic Hepatitis B
June 28, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.